Low Tumour Burden Follicular Lymphoma: Aster Medcity, Aster Center for Clinical Research is a participating center for a Government approved Phase III trial in patients with Previously Untreated, Stage II-IV, Cluster of Differentiation (CD)20-Positive, Low Tumour Burden Follicular Lymphoma After the initial screening patients who are eligible to participate in the study will be treated with an oral anti-cancer drug. For more details about the study please visit. http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=33639&EncHid=&userName=Follicular%20Lymphoma. You can also contact _9895311888/9495805590 at Aster Medcity for booking an appointment